Free Trial

Teva Pharmaceutical Industries (TEVA) SEC Filings & 10K Form

Teva Pharmaceutical Industries logo
$14.68 -0.68 (-4.39%)
Closing price 03/10/2025 03:59 PM Eastern
Extended Trading
$14.73 +0.04 (+0.31%)
As of 07:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Teva Pharmaceutical Industries SEC Filings

DateFilerForm TypeView
03/07/2025
3:22 PM
McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:25 PM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:29 PM
Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:13 PM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:16 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:06 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:08 PM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:11 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:13 PM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:29 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:08 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:14 PM
McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
03/04/2025
5:57 PM
McAvoy David R. (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:02 PM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:30 PM
Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:37 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:44 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:07 PM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:59 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:14 PM
Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
10:52 AM
Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
11:38 AM
Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
7:06 AM
Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
3:06 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:03 PM
BRIDGER MANAGEMENT, LLC (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:04 PM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
10:39 AM
Fox Christine (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
9:34 AM
FMR LLC (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SC 13G
11/06/2024
3:06 PM
Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
6:40 AM
Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:06 AM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
08/14/2024
5:24 AM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144/A
08/12/2024
3:09 PM
Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
6:32 AM
Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:35 AM
Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:30 AM
Jover Placid (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2024
3:06 PM
Teva Pharmaceutical Industries (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
6:00 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

06/25/2024
7:01 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:00 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:03 AM
Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:38 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:41 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:23 AM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:27 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:14 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:17 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:20 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:45 AM
MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:47 AM
Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:49 AM
Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:51 AM
Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:53 AM
Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:36 AM
Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:38 AM
LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:42 AM
Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:31 AM
BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:33 AM
Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:25 AM
Shields Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:18 AM
Shields Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/17/2024
6:41 AM
Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
7:30 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
7:36 AM
Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 AM
Teva Pharmaceutical Industries (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:12 PM
Teva Pharmaceutical Industries (Filer)
Form ARS
04/16/2024
3:16 PM
Teva Pharmaceutical Industries (Filer)
Form DEFA14A
04/09/2024
9:26 AM
Phoenix Holdings Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:TEVA) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners